Delivery Order SPE2DB22D3501-SPE2DB24FWF80

Award Date 7/11/24
Potential Completion Date 7/12/24
Potential Value $3.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical and medical supply distributor, by the Defense Logistics Agency (DLA). The award is a $1,360.17 delivery order under the DLA Troop Support Medical Indefinite Delivery Contract (IDC), valued up to $999,999,999 through December 2025. The contract is for the delivery of Qsymia 7.5 mg-46 mg capsules, a prescription medication. This order does not have a set-aside designation. Amerisourcebergen, through its...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,608.40 firm-fixed-price delivery order is for the supply of Qsymia 7.5 mg-46 mg capsules. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA for the delivery of a comprehensive range of medical commodities to support military treatment programs and facilities...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $1,463.52 firm-fixed price Delivery Order is for the supply of the prescription medication Qsymia 7.5 mg-46 mg capsules, with a completion date of June 27, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 2025. This single-award IDC...
This federal contract award is for the delivery of the prescription drug Qsymia 3.75 mg-23 mg capsules, in 30-count packages, to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,544.45 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp's Corporate Office division. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, to provide a comprehensive range of...
This is a federal contract award with a ceiling value of $6,117.60 from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Qsymia 7.5 mg-46 mg capsules, a medication used for weight management. The award is a delivery order under an Indefinite Delivery Contract (IDC) worth up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the delivery of Qsymia 15 mg-92 mg capsules. The $1,207.32 Firm Fixed Price Delivery Order contract has a completion date of July 22, 2024 and does not have a set-aside designation. As a key vendor for the DLA Troop Support Medical, AmerisourceBergen provides a wide range of pharmaceutical and medical supplies to support various government...
The U.S. government awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug QSYMIA 7.5MG-46MG 30S. The contract, valued at $1,663.14, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a unit of the Department of Defense (DoD). Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, worth up to $999,999,999.00 through December 2025, which serves as the...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of the medication Qsymia 3.75 mg-23 mg capsules. The award is a Delivery Order valued at $3,452.88 under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen, as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,239.78 firm-fixed-price delivery order is for the supply of the medication Qsymia in 3.75 mg-23 mg capsules. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award (SPE2DB20D3303 | SPE2DB24FZ6U6) was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,419.00 firm-fixed-price delivery order is for the supply of Qsymia 3.75 mg-23 mg capsules. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FWF80
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of Qsymia 7.5 mg-46 mg capsule in 30-count packages. The $3,150.08 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation, indicating it was awarded on a full and open competition basis. Amerisourcebergen, as a subsidiary of the larger Amerisourcebergen Corporation, leverages its extensive pharmaceutical distribution capabilities to fulfill government contracts for critical medical commodities.

Generated 10/10/24, 9:23 AM